Medtronic Digital Surgery’s Post

𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗕𝗮𝗿𝗿𝗶𝗲𝗿𝘀 𝗶𝗻 𝗘𝗻𝗱𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗖𝗮𝗿𝗲! Microbot Medical has taken a monumental step forward with the 𝗙𝗗𝗔 𝘀𝘂𝗯𝗺𝗶𝘀𝘀𝗶𝗼𝗻 of the 𝗟𝗜𝗕𝗘𝗥𝗧𝗬® 𝗘𝗻𝗱𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗥𝗼𝗯𝗼𝘁𝗶𝗰 𝗦𝘆𝘀𝘁𝗲𝗺—the world’s 𝗳𝗶𝗿𝘀𝘁 𝘀𝗶𝗻𝗴𝗹𝗲-𝘂𝘀𝗲, 𝗳𝘂𝗹𝗹𝘆 𝗱𝗶𝘀𝗽𝗼𝘀𝗮𝗯𝗹𝗲 𝗿𝗼𝗯𝗼𝘁𝗶𝗰 𝘀𝘆𝘀𝘁𝗲𝗺 for endovascular procedures. What does this mean for healthcare? 🔹 𝗘𝗻𝗵𝗮𝗻𝗰𝗲𝗱 𝘀𝗮𝗳𝗲𝘁𝘆 through single-use technology. 🔹 𝗦𝘁𝗿𝗲𝗮𝗺𝗹𝗶𝗻𝗲𝗱 𝗶𝗻𝘁𝗲𝗿𝘃𝗲𝗻𝘁𝗶𝗼𝗻𝘀 with robotic precision. 🔹 A 𝗽𝗮𝗿𝗮𝗱𝗶𝗴𝗺 𝘀𝗵𝗶𝗳𝘁 in peripheral vascular care. This cutting-edge advancement follows a successful multi-center trial, ensuring safety and performance in real-world scenarios. What could this innovation mean for your practice or patients?  Join the conversation and explore the future of robotic care in endovascular procedures. 🔗 https://lnkd.in/gRrk8MGb #HealthcareInnovation #RoboticSurgery #MedicalTechnology #Endovascular #MedicalDevices #HealthcareProfessionals

Bigger is Not Better! Significant Milestone for Stereotaxis and GenesisX! Stereotaxis just achieved a significant milestone, securing CE mark approval in Europe and submitting an FDA 510(k) application for their new GenesisX surgical robot. This cutting-edge system is a prime example of how medtech companies are moving towards surgical robotics platforms that are more accessible, smaller, and easier to implement and deploy, simplifying hospital integration and advancing patient care. GenesisX is a refined iteration of Stereotaxis' Genesis robotic magnetic navigation (RMN) system. It breaks down previous barriers by designing a more compact and efficient setup. Gone are the days of complex structural modifications and hefty installations. GenesisX uses smaller magnets and needs only standard power outlets, making it accessible for more hospitals. With these improvements, GenesisX promises swift, responsive performance and seamless workflow. As Stereotaxis aims for a full launch in 2025, the company plans to gather real-world data, secure additional regulatory approvals, and prepare the supply chain. This innovation opens doors for broader adoption in electrophysiology and endovascular procedures, bringing advanced robotic solutions to more patients. #MedTech #SurgicalRobotics #HealthcareInnovation

Microbot Medical announces FDA submission for the commercialization of the LIBERTY® Endovascular Robotic System. Learn more: https://lnkd.in/eaXqTCYd #robotics #roboticsurgery #surgicalrobotics #surgicalroboticstechnology #healthcare #medicaldevices

I was told I was mean. I was told I was unfair. I was told I was biased. That's okay. But I was asked specifically "Why are you so tough on JNJ and Medtronic and their surgical robotic programs?" So I've decided to do an open answer to this - anyone can read it. And it may surprise you as to why... it will not be what most people think. Read why here >> https://lnkd.in/e2_iyRKb #surgicalrobotics #roboticsurgery

🚀 Join us on 21 Sept at 18:00 CEST for an Interactive Case Discussion! 📅✨ 🔹 Admission Free 🔹 SCRN Members presenting cutting-edge robotic procedures 🔹 Knowledge sharing and progress in robotic labs Don't miss out on this chance to learn from the experts! 🤖🔧 #RoboticSurgery #MedicalInnovation #SCRN #FreeEvent #HealthcareTech

Guide your robotic steering committee to the 90th percentile in cost savings and case time efficiency. Learn how during the masterclass on Wednesday, May 29th, at 12 CST. https://ow.ly/ZKie50RGjiz Attendees Offered: The 21 Dimensions of CAVA Best Practices AND a review of your hospital console data with a brief written analysis. #roboticsurgery #roboticprogram #roboticsmasterclass #specialtycare #cavarobotics

𝗜𝗻𝘁𝘂𝗶𝘁𝗶𝘃𝗲 𝗦𝘂𝗿𝗴𝗶𝗰𝗮𝗹 𝘀𝘁𝗼𝗰𝗸 𝘀𝘂𝗿𝗴𝗲𝘀 𝟭𝟬% 𝗮𝗺𝗶𝗱 𝗱𝗮 𝗩𝗶𝗻𝗰𝗶 𝟱 𝗱𝗲𝗺𝗮𝗻𝗱, 𝘄𝗶𝘁𝗵 𝗳𝘂𝗹𝗹 𝗿𝗼𝗹𝗹𝗼𝘂𝘁 𝘀𝗲𝘁 𝗳𝗼𝗿 𝟮𝟬𝟮𝟱 Intuitive Surgical is advancing its da Vinci robot lineup with strong demand and increased installations, achieving significant financial and operational growth, while dealing with supply challenges and expanding global market approvals. 𝗞𝗲𝘆 𝗧𝗮𝗸𝗲𝗮𝘄𝗮𝘆𝘀 🟣Intuitive Surgical installed 110 new da Vinci 5 systems in Q3, planning full production by mid-2025. 🟣There is high demand for robotic, minimally invasive surgeries, despite supply challenges due to hurricanes. 🟣The company exceeded profit forecasts, boosting its stock price to over $521 per share. 🟣Since March, 188 da Vinci 5 units have performed over 12,000 procedures. Intuitive reported an 18% increase in procedure volume, driven by a global base of about 9,500 systems. 🟣Regulatory clearances are progressing, with approvals in South Korea and ongoing processes in Japan and Europe. 🟣Intuitive achieved $2.04 billion in revenue, attributed in part to growth in its endoluminal Ion system. More details: https://swiy.co/QO2I

BREAKING ❗ Are Intuitive going to enter the Handheld stapling and energy device market ? Are they going to use their power of the tower to full hand held laparoscopic effect ????? I am just speculating - but I have a very sound logical flow in an exclusive blog post - https://lnkd.in/dpRWHR3f Read my logic on why I believe this is going to happen and soon. Why I think #intuitive Intuitive will step right into the realm of Johnson & Johnson MedTech and Medtronic in manual lap. Well they have stepped on the toes of #daVinci with #Hugo and #ottava - so why not? Let me know in the comments if you find my arguments compelling and credible. This is all building to my post next week on who will own the stapler market - it's a big big thread I'm pulling on. #stapling #advancedenergy #surgicalrobotics #laparoscopy #roboticsurgery

Another great milestone we are creating in Asia!!! Please check out this video clip featured by Darla Hutton (VP, Asia Commercial Operations and Marketing) about the 2nd Asia Executive Summit where surgeons and hospital executives across the Asia region get together to exchange their insights about Robotic Assisted Surgery. #AsiaExecutiveSummit#June8th#Inspire#VirtualBroadcasting#Intuitive#DaVinci#Roboticsurgery

# Only put off until tomorrow what you are willing to die having left undone ## Seize the Opportunity to Grow Your HSA with Microbot Medical's LIBERTY® Endovascular Robotic System 💪 Don't miss out on this game-changing livestream interview with Microbot Medical CEO Harel Gadot! 📺 In a discussion today on Benzinga All Access, Gadot will dive deep into the revolutionary LIBERTY® Endovascular Robotic System. This cutting-edge technology is set to revolutionize the healthcare industry, and you have a chance to be part of it. 💼 Microbot Medical Inc.'s CEO, Harel Gadot, is scheduled to join the live interview at 10:50 am ET on December 10, 2024. Gain exclusive insights into the potential of the LIBERTY® system and how it can transform the field of endovascular procedures. 🏥 As an astute investor, it's important to stay ahead of the curve in the healthcare sector. By investing in companies like Microbot Medical, you not only support groundbreaking advancements but also capitalize on the financial opportunities they present. 🚀 Act now! Don't let the Fear of Missing Out hold you back. Secure your financial future, contribute to innovative healthcare solutions, and make the most of your Health Savings Account \(HSA\). #hsa #investing #healthcare #health #family #wellness 💰💡 Summary: Microbot Medical CEO Harel Gadot shares insights on the LIBERTY® Endovascular Robotic System in a livestream interview on Benzinga All Access. Investors are encouraged to seize this opportunity to grow their HSA by investing in cutting-edge healthcare technology. Take action now to avoid the fear of missing out and secure your financial future.